ClearNote Health to Present Avantect® Pancreatic Cancer Early Detection Data at ASCO 2026

ClearNote Health to Present New Multi-Cohort Validation Data for Avantect® Pancreatic Cancer Test at 2026 ASCO Annual Meeting ClearNote Health, a company focused on advancing early detection technologies for some of the most lethal cancers, announced that it will present…










